Home
>
National Drug Code (NDC)
>
ACTEMRA
ACTEMRA - 50242-135-04 - (tocilizumab)
Drug Information of ACTEMRA
| Product NDC: | 50242-135 |
| Proprietary Name: | ACTEMRA |
| Non Proprietary Name: | tocilizumab |
| Active Ingredient(s): | 20 mg/mL & nbsp; tocilizumab |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ACTEMRA
| Product NDC: | 50242-135 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125276 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20100108 |
Package Information of ACTEMRA
| Package NDC: | 50242-135-04 |
| Package Description: | 4 VIAL, SINGLE-USE in 1 BOX (50242-135-04) > 4 mL in 1 VIAL, SINGLE-USE |
NDC Information of ACTEMRA
| NDC Code | 50242-135-04 |
| Proprietary Name | ACTEMRA |
| Package Description | 4 VIAL, SINGLE-USE in 1 BOX (50242-135-04) > 4 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 50242-135 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | tocilizumab |
| Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20100108 |
| Marketing Category Name | BLA |
| Labeler Name | Genentech, Inc. |
| Substance Name | TOCILIZUMAB |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
